TAC1 and Alzheimer disease: In sum, PKC and IL-4 are original effectors inducing AD-like skin lesion, and our results suggests that Douchi reduces infiltration of degranulated mast cells and inflammatory mediators (substance P, MMP-9 and iNOS) through suppression of PKC and IL-4 activity.